878 related articles for article (PubMed ID: 23702928)
1. Neuroblastoma: developmental biology, cancer genomics and immunotherapy.
Cheung NK; Dyer MA
Nat Rev Cancer; 2013 Jun; 13(6):397-411. PubMed ID: 23702928
[TBL] [Abstract][Full Text] [Related]
2. New insights into the genetics of neuroblastoma.
Sridhar S; Al-Moallem B; Kamal H; Terrile M; Stallings RL
Mol Diagn Ther; 2013 Apr; 17(2):63-9. PubMed ID: 23329364
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma progress on many fronts: the Neuroblastoma Research Symposium.
Wylie L; Philpott A
Pediatr Blood Cancer; 2012 Apr; 58(4):649-51. PubMed ID: 21922652
[TBL] [Abstract][Full Text] [Related]
4. Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma.
Carpenter EL; Haglund EA; Mace EM; Deng D; Martinez D; Wood AC; Chow AK; Weiser DA; Belcastro LT; Winter C; Bresler SC; Vigny M; Mazot P; Asgharzadeh S; Seeger RC; Zhao H; Guo R; Christensen JG; Orange JS; Pawel BR; Lemmon MA; Mossé YP
Oncogene; 2012 Nov; 31(46):4859-67. PubMed ID: 22266870
[TBL] [Abstract][Full Text] [Related]
5. The ALK receptor in sympathetic neuron development and neuroblastoma.
Janoueix-Lerosey I; Lopez-Delisle L; Delattre O; Rohrer H
Cell Tissue Res; 2018 May; 372(2):325-337. PubMed ID: 29374774
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells.
Schönherr C; Ruuth K; Kamaraj S; Wang CL; Yang HL; Combaret V; Djos A; Martinsson T; Christensen JG; Palmer RH; Hallberg B
Oncogene; 2012 Dec; 31(50):5193-200. PubMed ID: 22286764
[TBL] [Abstract][Full Text] [Related]
7. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells.
Schulte JH; Lindner S; Bohrer A; Maurer J; De Preter K; Lefever S; Heukamp L; Schulte S; Molenaar J; Versteeg R; Thor T; Künkele A; Vandesompele J; Speleman F; Schorle H; Eggert A; Schramm A
Oncogene; 2013 Feb; 32(8):1059-65. PubMed ID: 22484425
[TBL] [Abstract][Full Text] [Related]
8. Copy number status and mutation analyses of anaplastic lymphoma kinase (ALK) gene in 90 sporadic neuroblastoma tumors.
Bagci O; Tumer S; Olgun N; Altungoz O
Cancer Lett; 2012 Apr; 317(1):72-7. PubMed ID: 22085494
[TBL] [Abstract][Full Text] [Related]
9. Targeting anaplastic lymphoma kinase in neuroblastoma.
Umapathy G; Mendoza-Garcia P; Hallberg B; Palmer RH
APMIS; 2019 May; 127(5):288-302. PubMed ID: 30803032
[TBL] [Abstract][Full Text] [Related]
10. Activated ALK collaborates with MYCN in neuroblastoma pathogenesis.
Zhu S; Lee JS; Guo F; Shin J; Perez-Atayde AR; Kutok JL; Rodig SJ; Neuberg DS; Helman D; Feng H; Stewart RA; Wang W; George RE; Kanki JP; Look AT
Cancer Cell; 2012 Mar; 21(3):362-73. PubMed ID: 22439933
[TBL] [Abstract][Full Text] [Related]
11. Immune therapies for neuroblastoma.
Navid F; Armstrong M; Barfield RC
Cancer Biol Ther; 2009 May; 8(10):874-82. PubMed ID: 19342881
[TBL] [Abstract][Full Text] [Related]
12. The connections between neural crest development and neuroblastoma.
Jiang M; Stanke J; Lahti JM
Curr Top Dev Biol; 2011; 94():77-127. PubMed ID: 21295685
[TBL] [Abstract][Full Text] [Related]
13. Neuroblastoma models for insights into tumorigenesis and new therapies.
Kiyonari S; Kadomatsu K
Expert Opin Drug Discov; 2015 Jan; 10(1):53-62. PubMed ID: 25345447
[TBL] [Abstract][Full Text] [Related]
14. Neuroblastoma: A Tough Nut to Crack.
Speleman F; Park JR; Henderson TO
Am Soc Clin Oncol Educ Book; 2016; 35():e548-57. PubMed ID: 27249766
[TBL] [Abstract][Full Text] [Related]
15. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.
Molenaar JJ; Koster J; Zwijnenburg DA; van Sluis P; Valentijn LJ; van der Ploeg I; Hamdi M; van Nes J; Westerman BA; van Arkel J; Ebus ME; Haneveld F; Lakeman A; Schild L; Molenaar P; Stroeken P; van Noesel MM; Ora I; Santo EE; Caron HN; Westerhout EM; Versteeg R
Nature; 2012 Feb; 483(7391):589-93. PubMed ID: 22367537
[TBL] [Abstract][Full Text] [Related]
16. Too many targets, not enough patients: rethinking neuroblastoma clinical trials.
Fletcher JI; Ziegler DS; Trahair TN; Marshall GM; Haber M; Norris MD
Nat Rev Cancer; 2018 Jun; 18(6):389-400. PubMed ID: 29632319
[TBL] [Abstract][Full Text] [Related]
17. The role of anaplastic lymphoma kinase in pediatric cancers.
Takita J
Cancer Sci; 2017 Oct; 108(10):1913-1920. PubMed ID: 28756644
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of neuroblastoma: present, past and future.
Raffaghello L; Pistoia V
Expert Rev Neurother; 2006 Apr; 6(4):509-18. PubMed ID: 16623650
[TBL] [Abstract][Full Text] [Related]
19. Studying the peripheral sympathetic nervous system and neuroblastoma in zebrafish.
Morrison MA; Zimmerman MW; Look AT; Stewart RA
Methods Cell Biol; 2016; 134():97-138. PubMed ID: 27312492
[TBL] [Abstract][Full Text] [Related]
20. Effect of missense mutations on structure and interaction of anaplastic Lymphoma kinase (ALK) in neuroblastom.
Kanwal H; Khan MH; Rashid H
Pak J Pharm Sci; 2013 May; 26(3):611-6. PubMed ID: 23625438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]